ZEOXZeo ScientifiX Inc.

About Zeo ScientifiX Inc. (ZEOX)

Zeo ScientifiX Inc. (ZEOX) is a Biotechnology company headquartered in Davie, FL, United States whose shares trade over-the-counter on the OTCQB tier.

We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company’s proprietary products, including Zofin™, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X™ (“PPX™”), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient’s own peripheral blood. Our products and related services are principally used in the health care industry administered through doctors and clinics. To date, the Company has obtained certain Investigational New Drug and 18 emergency IND approvals from the FDA, including applicable Institutional Review Board approvals which authorized the Company to commence clinical trials or treatments in connection with the use of Zofin™ and related treatment protocols.

Products and services

We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company’s proprietary products, including Zofin™, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X™ (“PPX™”), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient’s own peripheral blood. Our products and related services are principally used in the health care industry administered through doctors and clinics. To date, the Company has obtained certain Investigational New Drug and 18 emergency IND approvals from the FDA, including applicable Institutional Review Board approvals which authorized the Company to commence clinical trials or treatments in connection with the use of Zofin™ and related treatment protocols.

ZEOX key facts

Ticker symbol

ZEOX

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Davie, FL, United States

Country of incorporation

US

Employees

20

Estimated market cap

$11.48M (as of Apr 10, 2025)

Shares outstanding

6,344,817

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

10/31

Latest filing

8K Report (Apr 1, 2025)

Zeo ScientifiX Inc. leadership

• Ian T. Bothwell — Interim CEO, CFO
• George C. Shapiro — Chief Med. Officer
• Ron Borsheim — Chief Sales Officer
• Dr. Peter A.M. Everts, Ph.D. — Chief Scientific Officer, CTO

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with Z